Self-Associated Submicron IgG1 Particles for Pulmonary Delivery: Effects of Non-ionic Surfactants on Size, Shape, Stability, and Aerosol Performance

Abstract

Abstract. The ability to produce submicron particles of monoclonal antibodies of different sizes and shapes would enhance their application to pulmonary delivery. Although non-ionic surfactants are widely used as stabilizers in protein formulations, we hypothesized that non-ionic surfactants will affect the shape and size of submicron IgG particles manufactured through precipitation. Submicron particles of IgG1 were produced by a precipitation process which explores the fact that proteins have minimum solubility but maximum precipitation at the isoelectric point. Non-ionic surfactants were used for size and shape control, and as stabilizing agents. Aerosol performance of the antibody nanoparticles was assessed using Andersen Cascade Impactor. Spinhaler® and Handihaler® were used as model DPI devices. SEM micrographs revealed that the shape of the submicron particles was altered by varying the type of surfactant added to the precipitating medium. Particle size as measured by dynamic light scattering was also varied based on the type and concentration of the surfactant. The surfactants were able to stabilize the IgG during the precipitation process. Polyhedral, sponge-like, and spherical nanoparticles demonstrated improved aerosolization properties compared to irregularly shaped (>20 μm) unprocessed particles. Stable antibody submicron particles of different shapes and sizes were prepared. Careful control of the shape of such particles is critical to ensuring optimized lung delivery by dry powder inhalation.

Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation

“…The limited release of siRNA at pH 7 could be attributed to the reduced/limited solubility of IgG at the pH. Proteins are known to have limited solubility at pH values close to their isoelectric point (pI) [ 24 , 25 ]. Since the pI of IgG is 7, its solubility at neutral pH values is quite limited.…”

Nanoparticles Delivering Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Prevent Osteoporosis by Increasing Bone Formation

“…Isoelectric point (pI)-based nanoprecipitation technology [33][34][35] has been used to prepare nanoparticles. As reported previously, the nanoparticles protect loaded agomir-483-5p or antagomir-483-5p against serum nuclease without inducing the in ammatory response of macrophages while escaping endocytic recycling.…”

Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates

“…In the United states, only a five-year survival rate of 15% has been achieved for all stages of NSCLC [1,2]. Recent breakthroughs in the development of chemotherapy has not reflected significantly in cure rates, which still stands at less than 18% [3]. Due to the fact that cytoreductive surgery has not been very effective because of the quick spread of NSCLC, chemotherapy in combination with radiotherapy has been the treatments of choice.…”

“…Due to the fact that cytoreductive surgery has not been very effective because of the quick spread of NSCLC, chemotherapy in combination with radiotherapy has been the treatments of choice. However, resistance of cancer cells to chemotherapy has led to limited efficacy of conventional chemotherapy [3,4,5]. The investment of several billions of dollars in research on cancer drug development has not had any substantial decrease in mortality for several decades [6].…”